Clinical Trial Update: Octreotide in Severe Polycystic Liver Disease [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports completion and posted results for phase 2/3 studies of octreotide in severe polycystic liver disease, sponsored by Mayo Clini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Polycystic Liver Disease

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Mayo Clinic | Conditions: Polycystic Kidney, Autosomal Dominant, Polycystic Liver Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-11-21